Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells

GLIA

Volumn 26, Issue 3, 1999, Pages 201-211

  Davoust, Nathalie ^a   Jones, Jennifer ^a   Stahel, Philip F ^b   Ames, Robert S ^c   Barnum, Scott R ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c GLAXOSMITHKLINE   (United Kingdom)

^d University of Alabama at Birmingham   (United States)

Author keywords

Chemotactic receptor; EAE; Mouse; Rat

Indexed keywords

ALLERGIC ENCEPHALITIS; ANAPHYLATOXIN 3A RECEPTOR; CELL CULTURE; CENTRAL NERVOUS SYSTEM; COMPLEMENT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MACROPHAGE; MESSENGER RNA; MONOCYTE; NERVE CELL; RECEPTOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033134789     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M     Document Type: Article

References (36)

1. Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C, Zeng Z, Su K, Jurewicz AJ, Hertzberg RP, Bergsma DJ, Kumar C. 1996. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271:20231-20234.
2. Armstrong RC, Harvath L, Dubois-Dalcq ME. 1990. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27:400-407.
3. Biedler JL, Kelson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
4. Crass T, Raffetseder U, Martin U, Grove M, Klos A, Köhl J, Bautsch W. 1996. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol 26:1944-1950.
5. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:2119-2127.
6. Elsner J, Oppermann M, Czech W, Dobos G, Schöpf E, Norgauer J, Kapp A. 1994. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 24:518-522.
7. Ember JA, Jagals MA, Hugli TE. 1998. Characterization of complement anaphylatoxins and their biological responses. In: The human complement system in health and disease. Volanakis JE, Frank MM, editors. New York: Marcel Dekker. p 241-284.
8. Feurer C, Prentice DE, Cammisuli S. 1985. Chronic relapsing encephalomyelitis in the Lewis rat. J Neuroimmunol 10:159-65.
9. desArg. Suppression of TNF-α, IL-6, and polyclonal immune response. J Immunol 159:4279-4286.
10. Gasque P, Chan P, Fontaine M, Ishenko A, Lamacz M, Götze O, Morgan BP. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J Immunol 155:4882-4889.
11. Gasque P, Singhrao SK, Neal JW, Götze O, Morgan BP. 1997. Expression of the receptor for the complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol 150:31-41.
12. Gasque P, Singhrao SK, Neal JW, Wang P, Sayah S, Fontaine M, Morgan BP. 1998. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and non myeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immunol 160:3543-3554.
13. Heese K, Hock C, Otten U. 1998. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 70:699-707.
14. Hsu MH, Ember JA, Wang M, Prossnitz ER, Hugli TE, Ye RD. 1997. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics 47:64-72.
15. 125I-C3a binding. Biochemistry 31:11274-11282.
16. Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR. 1995. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol 61:71-78.
17. Legler DF, Loetscher M, Jones SA, Dahinden CA, Arock MA, Moser B. 1996. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol 26:753-758.
18. Martin U, Bock D, Arseniev L, Tornetta MA, Ames R, Bautsch W, Köhl J, Ganser A, Klos A. 1997. The human C3a receptor is expressed on neutrophils and monocytes but not on B or T lymphocytes. J Exp Med 2:199-207.
19. i signaling in mouse microglia. J Neurosci 17:615-624.
20. Müller-Ladner U, Jones JL, Wetsel RA, Gay S, Raine CS, Barnum SR. 1996. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J Neurol Sci 144:135-141.
21. Nataf S, Davoust N, Barnum SR. 1998. Kinetics of C5aR expression during experimental allergic encephalomyelitis. J Neuroimmunol 91:147-155.
22. Nilson G, Johnell M, Hammer CH, Tiffany HL, Nilson K, Metcalfe DD, Siegbahn A, Murphy PM. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693-1698.
23. Nolte C Moller, T Walter T, Kettenmann H. 1996. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actincytoskeleton. Neuroscience 73:1091-1107.
24. Raff MC, Miller RH, Noble M. 1983. A glial progenitor cell that develops in vitro into astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390-396.
25. Roth J, Saremaslani P, Warhol MJ, Heitz PU. 1992. Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification. Lab Invest 67:263-269.
26. Roglic A, Prossnitz ER, Cavanagh SL, Pan Z, Zou A, Ye RD. 1996. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim BiophysActa 1305:39-43.
27. Schupf N, Williams CA, Hugh TE, Cox J. 1983. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J Neuroimmunol 5:305-316.
28. Spiegel K, Emmerling MR, Barnum SR. 1997. Strategies for inhibition of complement activation in the treatment of neurodegenerative diseases. In: Wood P, editor. Neurodegeneration: inflammatory mechanisms and management. Totowa: Humana Press, p 129-176.
29. Stahel PF, Frei K, Eugster H-P, Fontana A, Hummel KM, Wetsel RA, Ames RS, Barnum SR. 1997a. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningocephalitis. J Immunol 159:861-869.
30. Stahel PF, Kossmann T, Hans V, Morganti-Kossmann MC, Barnum SR. 1997b. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor m RNA expression in rats. Mol Brain Res 150:205-212.
31. Sundstrom C, Nilsson K. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int J Cancer 17:565-577.
32. Takabayashi T, Vannier E, Clark BD, Margolis NH, Dinarello CA, Burke JF, Gelfand JA. 1996. A new biologic role for C3a and C3a desArg. Regulation of TNF-α and IL-1β synthesis. J Immunol 156:3455-3460.
33. Tornetta MA, Foley JJ, Sarau HM, Ames RS. 1997. The mouse anaphylatoxin C3a receptor. Molecular cloning, genomic organization, and functional expression. J Immunol 158:5277-5282.
34. Vidovic M, Sparacio SM, Elovitz M, Benveniste EN. 1990. Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α. J Neuroimmunol 30:189-200.
35. Whittemore SR, Sanon HR, Wood PM. 1993. Concurrent isolation and characterization of oligodendrocytes, microglia and astrocytes from adult human spinal cord. Int J Dev Neurosci 11:755-764.
36. Williams CA, Schupf N, Reilly CL, Wagner J. 1988. Complement peptides and neuronal dysfunction in the central nervous system: specificity of receptor sites for anaphylatoxin C3a activity in the rat hypothalamus. Drug Dev Res 15:175-187.